Skip to main content
Clinical Trials/CTRI/2020/04/024866
CTRI/2020/04/024866
Completed
Phase 1

A randomized comparative clinical study to evaluate the efficacy of gorakhmundi churna & shunthyadi kwath in the management of dhatvagnimandhya w.s.r. to subclinical hypothyroidism

Ayurvedic and Unani Tibbia College and hospital0 sites60 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Ayurvedic and Unani Tibbia College and hospital
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 14, 2021
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ayurvedic and Unani Tibbia College and hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient willing to participate in the trial and sign the consent form.
  • 2\. The patients between the age group of 16 to 60 years in either sex.
  • 3\. Patients of hypothyroidism with features mentioned in subjective parameters.
  • 4\. On the basis of raised serum TSH(5\-10mIu/l) and normal serum T4 level.
  • 5\. Patient already taking modern medicine (Thyroxine).

Exclusion Criteria

  • 1\. Patients who were not willing for trial.
  • 2\. Patient below the age of 16 years and above 60 years.
  • 3\. TSH level more than 10 or less than 5\.
  • 4\. Patients who are suffering from hypothyroidism for more than 10 year.
  • 5\. Patients suffering from any other systemic illness Diabetes, HTN, liver disorder,
  • tuberculosis etc.
  • 6\. Pregnant and lactating patients.
  • 7\. Patients taking antibiotic therapy for any systemic illness within 2 months.
  • 8\. H/O of hypersensitivity of any trail drug.
  • 9\. Patient who fail to give consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials